Menu

Seven More Retractions for Cancer Researcher

All of the papers had been published in the Journal of Biological Chemistry.

Aug 10, 2016
Kerry Grens

WIKIMEDIA, NATIONAL CANCER INSTITUTEBharat Aggarwal, a former investigator at MD Anderson Cancer Center, has racked up 18 retractions, seven of which were issued by the Journal of Biological Chemistry on August 5. As Retraction Watch reported, the latest retractions all have to do with image tampering.

Several of the retraction notices reference an investigation conducted by MD Anderson that revealed the improper image manipulations. In all of the suspect papers, images had been reused to represent different experimental conditions.

As Retraction Watch pointed out, Aggrawal had been held in high regard by the scientific community, and several papers he coauthored earned more than 1,000 citations apiece. The disgraced researcher now has another claim to fame: joining Retraction Watch’s list of most-retracted authors.  

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.